TY - JOUR
T1 - Randomization, design and analysis for interdependency in aging research
T2 - no person or mouse is an island
AU - Chusyd, Daniella E.
AU - Austad, Steven N.
AU - Dickinson, Stephanie L.
AU - Ejima, Keisuke
AU - Gadbury, Gary L.
AU - Golzarri-Arroyo, Lilian
AU - Holden, Richard J.
AU - Jamshidi-Naeini, Yasaman
AU - Landsittel, Doug
AU - Mehta, Tapan
AU - Oakes, J. Michael
AU - Owora, Arthur H.
AU - Pavela, Greg
AU - Rojo, Javier
AU - Sandel, Michael W.
AU - Smith, Daniel L.
AU - Vorland, Colby J.
AU - Xun, Pengcheng
AU - Zoh, Roger
AU - Allison, David B.
N1 - Publisher Copyright:
© 2022, Springer Nature America, Inc.
PY - 2022/12
Y1 - 2022/12
N2 - Investigators traditionally use randomized designs and corresponding analysis procedures to make causal inferences about the effects of interventions, assuming independence between an individual’s outcome and treatment assignment and the outcomes of other individuals in the study. Often, such independence may not hold. We provide examples of interdependency in model organism studies and human trials and group effects in aging research and then discuss methodologic issues and solutions. We group methodologic issues as they pertain to (1) single-stage individually randomized trials; (2) cluster-randomized controlled trials; (3) pseudo-cluster-randomized trials; (4) individually randomized group treatment; and (5) two-stage randomized designs. Although we present possible strategies for design and analysis to improve the rigor, accuracy and reproducibility of the science, we also acknowledge real-world constraints. Consequences of nonadherence, differential attrition or missing data, unintended exposure to multiple treatments and other practical realities can be reduced with careful planning, proper study designs and best practices.
AB - Investigators traditionally use randomized designs and corresponding analysis procedures to make causal inferences about the effects of interventions, assuming independence between an individual’s outcome and treatment assignment and the outcomes of other individuals in the study. Often, such independence may not hold. We provide examples of interdependency in model organism studies and human trials and group effects in aging research and then discuss methodologic issues and solutions. We group methodologic issues as they pertain to (1) single-stage individually randomized trials; (2) cluster-randomized controlled trials; (3) pseudo-cluster-randomized trials; (4) individually randomized group treatment; and (5) two-stage randomized designs. Although we present possible strategies for design and analysis to improve the rigor, accuracy and reproducibility of the science, we also acknowledge real-world constraints. Consequences of nonadherence, differential attrition or missing data, unintended exposure to multiple treatments and other practical realities can be reduced with careful planning, proper study designs and best practices.
UR - https://www.scopus.com/pages/publications/85144642860
U2 - 10.1038/s43587-022-00333-6
DO - 10.1038/s43587-022-00333-6
M3 - Article
AN - SCOPUS:85144642860
SN - 2662-8465
VL - 2
SP - 1101
EP - 1111
JO - Nature Aging
JF - Nature Aging
IS - 12
ER -